Navigation Links
Statement by Teva Pharmaceuticals on Eshoo-Barton Bill
Date:3/17/2009

NORTH WALES, Pa., March 17 /PRNewswire-USNewswire/ -- Teva Pharmaceuticals USA, the leading generic pharmaceutical company, today released the following statement by Debra Barrett, Senior Vice President of Government Affairs on the introduction of a biogenerics bill by Representatives Anna Eshoo and Joe Barton:

"In this year of healthcare reform, consumers should rightfully demand better access to affordable medicines. The legislation re-introduced in the House today is clearly written to protect brand-name drugs and their innovator's government-granted monopoly at the expense of access and innovation. This bill will dampen innovation and deny Americans access to more affordable healthcare.

"Congress took a bold step in 1984 when it passed Hatch-Waxman - an effort that led to the greatest explosion of innovative medicines in history - while creating a pathway for more affordable alternatives. We hope that our policymakers will enact legislation that puts the interests of patients above the guarantee of excessive monopoly."

About Teva

Teva USA is a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd., one of the largest generic pharmaceutical companies in the world and among the top 20 pharmaceutical companies. For more information, please visit www.tevausa.com or www.tevadc.com.

    Media Contact: Denise Bradley
    Phone: (215) 591-8974
    E-mail: Denise.Bradley@tevausa.com


'/>"/>
SOURCE Teva Pharmaceuticals USA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Statement by Shelby Knox on the Introduction of the REAL Act
2. Grocery Manufacturers Association Statement Regarding President Obamas Nomination of FDA Commissioner
3. GPhA Statement on Nomination of Dr. Margaret Hamburg as Commissioner and Dr. Joshua Sharfstein as Deputy Commissioner of FDA
4. AJWS Asks International Community to Demand Reinstatement of International Aid Groups Into Sudan
5. Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND
6. Pelosi Statement on President Obamas Executive Order on Stem Cell Research
7. AHIP Statement on White House Health Care Summit
8. Change to Win Statement on White House Health Care Forum
9. Statement by Bruce Bodaken, Chairman & CEO, Blue Shield of California, Regarding President Obamas Healthcare Summit
10. AAJ Statement on Supreme Court Decision in Favor of Diana Levine
11. NJLRA Statement on Todays U.S. Supreme Courts Decision in Wyeth v. Levine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... , ... LELO has discovered many people are insecure about their ... email, social media and on the Volonté blog seeking advice about how to actually ... or ‘correct’?” , While some methods are more common than others, there is no ...
(Date:5/5/2016)... ... May 05, 2016 , ... An essential tool ... states and certain Canadian provinces is now available from the International Association of ... , The report, Workers’ Compensation Laws as of January 1, 2016, ...
(Date:5/5/2016)... York (PRWEB) , ... May 05, 2016 , ... Long ... announced the merger of noted Long Island eye surgeon, Kathleen Van Valkenburg, MD as ... practice, according to Jeffrey Martin, MD, medical director and managing partner of North Shore ...
(Date:5/5/2016)... ... May 05, 2016 , ... Standard Process Inc. ... across the United States. The whole food nutrient solutions company can help veterinarians ... dog, cat and horse owners’ peace of mind. With the increased support, veterinarian ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... to people’s every day living patterns, Amerec, a Seattle-based steam bath and sauna ... phone app. , The user interface of the app, developed for both smartphones ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... May 4, 2016 According to ... entitled "Brain Computer Interface Market - Global Industry Analysis, Size, ... brain computer interface (BCI) market  is expected to reach ... is estimated to expand at a CAGR of 14.9 ... A BCI device provides collaboration between the ...
(Date:5/4/2016)... May 4, 2016 According to market ... and Demand Forecast to 2022 - Industry Insights by Slice ... Center and Others)" by P&S Market Research, the global ... 2015, and it is expected to grow at a CAGR ... slice type segment is expected to witness the faster growth, ...
(Date:5/4/2016)... New Jersey , May 4, 2016 ... its successful completion of an alternative public offering (APO). ... wholly owned operating company, Valeritas, Inc. and a private ... common stock at $5.00 per share. Under ... on May 3, 2016, Valeritas Holdings, Inc. will trade ...
Breaking Medicine Technology: